Cardiff Oncology, Inc. - Penyata Pendapatan (TTM)

Cardiff Oncology, Inc.
US ˙ NasdaqCM ˙ US14147L1089

Penyata Pendapatan (TTM)

Cardiff Oncology, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1
Perubahan (%) 7.78 1.09 7.03 -12.88 4.06 0.56 6.37 1.82 -1.28 2.33 4.30 11.65 6.09 25.00 9.02 3.46 -0.73 -14.06 -7.16
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 11 11 12 13 15 17 21 25 26 27 29 30 32 33 32 33 35 37 39 41
Perubahan (%) 3.07 5.10 13.92 9.66 17.80 22.61 15.63 7.53 2.33 6.80 1.98 6.82 4.19 -3.18 4.63 4.86 5.58 6.70 5.31
% daripada Hasil 3,210.01 3,069.67 3,191.35 3,396.97 4,275.65 4,840.11 5,901.66 6,415.10 6,774.68 7,022.54 7,329.37 7,165.78 6,855.65 6,732.99 5,215.25 5,005.41 5,073.11 5,395.61 6,698.64 7,597.80
Keuntungan Operasi Kasar -11 -11 -11 -13 -14 -17 -21 -24 -26 -27 -29 -29 -31 -32 -31 -33 -34 -36 -39 -41
Perubahan (%) 2.92 5.24 14.15 10.34 18.12 23.08 15.78 7.62 2.39 6.87 1.94 6.75 4.16 -3.60 4.54 4.89 5.71 7.09 5.50
% daripada Hasil -3,110.02 -2,969.67 -3,091.35 -3,296.97 -4,175.65 -4,740.11 -5,801.66 -6,315.10 -6,674.68 -6,922.54 -7,229.37 -7,065.78 -6,755.65 -6,632.99 -5,115.25 -4,905.41 -4,973.11 -5,295.61 -6,598.64 -7,497.80
SG&A 6 8 9 10 11 12 14 14 14 13 12 14 13 13 13 12 12 12 13 13
Perubahan (%) 30.07 9.12 13.04 12.68 3.66 14.40 1.83 1.07 -5.43 -6.50 9.82 -1.02 -2.64 0.36 -8.26 1.56 2.35 7.08 0.77
% daripada Hasil 1,860.37 2,245.08 2,423.24 2,559.34 3,310.14 3,297.49 3,751.52 3,591.41 3,564.71 3,414.77 3,120.00 3,284.95 2,912.17 2,672.75 2,145.90 1,805.86 1,772.67 1,827.53 2,277.00 2,471.38
R&D
Perubahan (%)
% daripada Hasil
OpEx 17 19 21 24 26 29 35 38 40 40 41 43 45 46 45 45 47 49 53 55
Perubahan (%) 12.98 6.80 13.54 10.96 11.63 19.29 10.26 5.21 -0.34 2.45 4.32 4.35 2.15 -2.17 0.87 3.98 4.75 6.80 4.16
% daripada Hasil 5,070.39 5,314.75 5,614.59 5,956.31 7,585.80 8,137.60 9,653.19 10,006.51 10,339.39 10,437.31 10,449.37 10,450.73 9,767.83 9,405.74 7,361.15 6,811.28 6,845.78 7,223.13 8,975.64 10,069.17
Pendapatan operasi -17 -19 -20 -23 -26 -29 -34 -38 -40 -40 -41 -43 -44 -45 -44 -45 -46 -49 -52 -54
Perubahan (%) 13.08 6.91 13.66 11.36 11.73 19.52 10.31 5.24 -0.33 2.45 4.32 4.28 2.11 -2.46 0.76 3.99 4.83 7.09 4.28
% daripada Hasil -4,970.39 -5,214.75 -5,514.59 -5,856.31 -7,485.80 -8,037.60 -9,553.19 -9,906.51 -10,239.39 -10,337.31 -10,349.37 -10,350.73 -9,667.83 -9,305.74 -7,261.15 -6,711.28 -6,745.78 -7,123.13 -8,875.64 -9,969.17
Perbelanjaan Faedah -0 -0 -0 -0
Perubahan (%) -0.00 -0.00 -0.00
% daripada Hasil -0.55 -0.54 -0.51 -0.58
Pendapatan bersih -17 -19 -20 -23 -25 -28 -34 -38 -39 -39 -39 -40 -41 -41 -40 -41 -43 -45 -49 -51
Perubahan (%) 13.89 5.65 12.91 10.49 11.18 20.55 10.81 4.39 -1.89 0.59 1.82 2.93 1.57 -2.92 1.56 5.20 5.70 7.53 4.43
% daripada Hasil -4,992.25 -5,275.14 -5,512.70 -5,815.66 -7,375.65 -7,880.50 -9,447.37 -9,841.41 -10,089.26 -10,026.94 -9,856.71 -9,621.60 -8,869.78 -8,492.01 -6,594.92 -6,143.91 -6,247.24 -6,651.68 -8,322.66 -9,361.28

Source: Capital IQ

Other Listings
DE:XE7C €1.75
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista